Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
Status:
Terminated
Trial end date:
2018-01-12
Target enrollment:
Participant gender:
Summary
Phase 3, international, multicenter, randomized, double-blind, placebo-controlled,
parallel-group, 3-arm safety and efficacy study (Part A) with an open-label phase (Part B).